91 related articles for article (PubMed ID: 15591719)
1. Trofosfamide in the palliative treatment of cancer: a review of the literature.
Latz D; Nassar N; Frank R
Onkologie; 2004 Dec; 27(6):572-6. PubMed ID: 15591719
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas.
Hartmann JT; Oechsle K; Mayer F; Kanz L; Bokemeyer C
Anticancer Res; 2003; 23(2C):1899-901. PubMed ID: 12820475
[TBL] [Abstract][Full Text] [Related]
3. Trofosfamide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the oral treatment of cancer.
Wagner A; Hempel G; Boos J
Anticancer Drugs; 1997 Jun; 8(5):419-31. PubMed ID: 9215603
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide: new idications-new dose strength. Limited evidence of effectiveness.
Prescrire Int; 1998 Apr; 7(34):45-7. PubMed ID: 10183382
[TBL] [Abstract][Full Text] [Related]
5. Oral trofosfamide: an active drug in the treatment of soft-tissue sarcoma.
Blomqvist C; Wiklund T; Pajunen M; Virolainen M; Elomaa I
Cancer Chemother Pharmacol; 1995; 36(3):263-5. PubMed ID: 7781149
[TBL] [Abstract][Full Text] [Related]
6. [Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors].
Gary-Bobo J
J Radiol Electrol Med Nucl; 1971 Dec; 52(12):858-62. PubMed ID: 4113798
[No Abstract] [Full Text] [Related]
7. Palliative chemotherapy with trofosfamide in advanced prostate cancer.
Salminen EK; Sundström J; Nikkanen V
Anticancer Res; 2006; 26(1B):539-42. PubMed ID: 16739316
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma.
Kollmannsberger C; Brugger W; Hartmann JT; Maurer F; Böhm P; Kanz L; Bokemeyer C
Anticancer Drugs; 1999 Jun; 10(5):453-6. PubMed ID: 10477164
[TBL] [Abstract][Full Text] [Related]
9. [1st clinical experiences with isophosphamide. Long-term results of 2 therapeutic approaches].
Pigatto JC
Prensa Med Argent; 1971 Oct; 58(32):1618-21. PubMed ID: 4943249
[No Abstract] [Full Text] [Related]
10. Mafosfamide as a new anticancer agent: preclinical investigations and clinical trials.
Mazur L; Opydo-Chanek M; Stojak M; Wojcieszek K
Anticancer Res; 2012 Jul; 32(7):2783-9. PubMed ID: 22753738
[TBL] [Abstract][Full Text] [Related]
11. Trofosfamide as a salvage treatment with low toxicity in malignant lymphoma. A phase II study.
Helsing MD
Eur J Cancer; 1997 Mar; 33(3):500-2. PubMed ID: 9155539
[TBL] [Abstract][Full Text] [Related]
12. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines.
Hartmann JT
Anticancer Drugs; 2007 Mar; 18(3):245-54. PubMed ID: 17264755
[TBL] [Abstract][Full Text] [Related]
13. Partial response of metastatic mucosal melanoma after palliative chemotherapy with trofosfamide: a case report.
Aigner B; Richtig E; Becker JC; Lingitz H; Marterer R; Niederkorn A; Ugurel S
J Clin Oncol; 2013 Jan; 31(2):e31-2. PubMed ID: 23213097
[No Abstract] [Full Text] [Related]
14. Dose escalation study for defining the maximum tolerated dose of continuous oral trofosfamide in pretreated patients with metastatic lung cancer.
Al-Batran SE; Atmaca A; Bert F; Jäger D; Frisch C; Neumann A; Orth J; Knuth A; Jäger E
Onkologie; 2004 Dec; 27(6):534-8. PubMed ID: 15591711
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma.
Reichle A; Bross K; Vogt T; Bataille F; Wild P; Berand A; Krause SW; Andreesen R
Cancer; 2004 Nov; 101(10):2247-56. PubMed ID: 15470711
[TBL] [Abstract][Full Text] [Related]
16. Relevance of high-dose chemotherapy in solid tumours.
Nieboer P; de Vries EG; Mulder NH; van der Graaf WT
Cancer Treat Rev; 2005 May; 31(3):210-25. PubMed ID: 15944050
[TBL] [Abstract][Full Text] [Related]
17. Palliative chemotherapy of adult soft tissue sarcomas.
Budd GT
Semin Oncol; 1995 Apr; 22(2 Suppl 3):30-4. PubMed ID: 7537901
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy in non-Hodgkin's lymphomas (author's transl)].
Schmidt CG
Strahlentherapie; 1977 May; 153(5):283-92. PubMed ID: 69343
[TBL] [Abstract][Full Text] [Related]
19. Complete remission of relapsing high-grade angiosarcoma with single-agent metronomic trofosfamide.
Kopp HG; Kanz L; Hartmann JT
Anticancer Drugs; 2006 Sep; 17(8):997-8. PubMed ID: 16940811
[TBL] [Abstract][Full Text] [Related]
20. [Malignant lymphoma associated with HIV infection].
Mitrou PS; Serke M; Pohl C; Becker K; Schrappe-Bächer M; Knauf W; Westerhausen M; Clemens MR; Helm EB; Fischer T
Dtsch Med Wochenschr; 1991 Aug; 116(33):1217-23. PubMed ID: 1874122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
